Skip to main content
SpringerLink
Log in

AEs after homologous versus heterologous COVID-19 booster

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rzymski P, et al. Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine Vaccines : 2 Jun 2022. Available from: URL: https://doi.org/10.3390/vaccines10050754

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AEs after homologous versus heterologous COVID-19 booster. Reactions Weekly 1910, 5 (2022). https://doi.org/10.1007/s40278-022-16840-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16840-1

Search

Navigation